Dr Israel Robert Grossman, MD - Medicare Hematology/oncology in Livingston, NJ

Dr Israel Robert Grossman, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Livingston, New Jersey. He went to Yale University School Of Medicine and graduated in 1993 and has 31 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Medical Oncology Associates At Saint Barnabas, Barnabas Health Medical Group Pc and his current practice location is 94 Old Short Hills Rd, Livingston, New Jersey. You can reach out to his office (for appointments etc.) via phone at (973) 322-5200.

Dr Israel Robert Grossman is licensed to practice in New Jersey (license number 25MA07279900) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1255311445.

Contact Information

Dr Israel Robert Grossman, MD
94 Old Short Hills Rd,
Livingston, NJ 07039-5672
(973) 322-5200
Not Available



Physician's Profile

Full NameDr Israel Robert Grossman
GenderMale
SpecialityHematology/oncology
Experience31 Years
Location94 Old Short Hills Rd, Livingston, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Israel Robert Grossman attended and graduated from Yale University School Of Medicine in 1993
  NPI Data:
  • NPI Number: 1255311445
  • Provider Enumeration Date: 01/23/2006
  • Last Update Date: 06/11/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 5496712317
  • Enrollment ID: I20041213000590

Medical Identifiers

Medical identifiers for Dr Israel Robert Grossman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1255311445NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 25MA07279900 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Saint Barnabas Medical CenterLivingston, NJHospital
Morristown Medical CenterMorristown, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Medical Oncology Associates At Saint Barnabas054722038611
Barnabas Health Medical Group Pc9537316955558

News Archive

CRC net revenue increases 3% to $108.9M for three months ended March 31, 2012

CRC Health Corporation, a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three months ended March 31, 2012.

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

Caffeine may help older women protect their thinking skills

Caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology ®, the medical journal of the American Academy of Neurology.

UC study finds coping mechanisms that helped COVID-19 patients deal with loss of smell

One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Together with colleagues from the University of Palermo, KFU employees offer a nano preparation based on biocompatible halloysite nanotubes and bacterial pigment prodigiosin; the latter is known to selectively disrupt cancer cells without damaging the healthy ones.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Israel Robert Grossman allows following entities to bill medicare on his behalf.
Entity NameMedical Oncology Associates At Saint Barnabas
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689622748
PECOS PAC ID: 0547220386
Enrollment ID: O20041015000127

News Archive

CRC net revenue increases 3% to $108.9M for three months ended March 31, 2012

CRC Health Corporation, a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three months ended March 31, 2012.

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

Caffeine may help older women protect their thinking skills

Caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology ®, the medical journal of the American Academy of Neurology.

UC study finds coping mechanisms that helped COVID-19 patients deal with loss of smell

One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Together with colleagues from the University of Palermo, KFU employees offer a nano preparation based on biocompatible halloysite nanotubes and bacterial pigment prodigiosin; the latter is known to selectively disrupt cancer cells without damaging the healthy ones.

Read more Medical News

› Verified 3 days ago

Entity NameBarnabas Health Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841557246
PECOS PAC ID: 9537316955
Enrollment ID: O20120820000951

News Archive

CRC net revenue increases 3% to $108.9M for three months ended March 31, 2012

CRC Health Corporation, a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three months ended March 31, 2012.

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

Caffeine may help older women protect their thinking skills

Caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology ®, the medical journal of the American Academy of Neurology.

UC study finds coping mechanisms that helped COVID-19 patients deal with loss of smell

One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Together with colleagues from the University of Palermo, KFU employees offer a nano preparation based on biocompatible halloysite nanotubes and bacterial pigment prodigiosin; the latter is known to selectively disrupt cancer cells without damaging the healthy ones.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Israel Robert Grossman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Israel Robert Grossman, MD
205 W 15th St,
New York, NY 10011-6418

Ph: (973) 322-5200
Dr Israel Robert Grossman, MD
94 Old Short Hills Rd,
Livingston, NJ 07039-5672

Ph: (973) 322-5200

News Archive

CRC net revenue increases 3% to $108.9M for three months ended March 31, 2012

CRC Health Corporation, a leading provider of substance abuse treatment and adolescent youth services through its wholly owned consolidated subsidiaries, announced its results for the three months ended March 31, 2012.

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conducted in this population.

Caffeine may help older women protect their thinking skills

Caffeine may help older women protect their thinking skills, according to a study published in the August 7, 2007, issue of Neurology ®, the medical journal of the American Academy of Neurology.

UC study finds coping mechanisms that helped COVID-19 patients deal with loss of smell

One of the most common and disturbing side effects of COVID-19 is the loss of the sense of smell. New research from the University of Cincinnati found some common coping mechanisms that helped COVID-19 patients deal with a lessened sense of smell, which severely impacts the sense of taste.

Prodigiosin-based nanoformulation selectively disrupts cancer cells

Together with colleagues from the University of Palermo, KFU employees offer a nano preparation based on biocompatible halloysite nanotubes and bacterial pigment prodigiosin; the latter is known to selectively disrupt cancer cells without damaging the healthy ones.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Livingston, NJ

Bilal Khan,
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 646-591-5953    
Dr. Bruce Joseph Haik, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Road Suite 2511, Livingston, NJ 07039
Phone: 973-731-9442    Fax: 973-731-2918
Parvathy Thiruwilwamala, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039
Phone: 973-322-5000    
Dr. Michael Gutkin, M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 349 E Northfield Rd, Suite 202, Livingston, NJ 07039
Phone: 973-597-1107    Fax: 973-597-1407
Dr. Eugene Ludwig Evans Jr., M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 2 W Northfield Rd, Suite 211, Livingston, NJ 07039
Phone: 973-758-0044    Fax: 973-758-0055
Dr. Stuart E Baskin, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 315 E Northfield Rd, Suite 1a, Livingston, NJ 07039
Phone: 973-994-2121    Fax: 973-535-8191
Jill Ritter, MD
Hematology & Oncology
Medicare: May Accept Medicare Assignments
Practice Location: 200 S Orange Ave, Livingston, NJ 07039
Phone: 973-322-7400    Fax: 973-322-7420

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.